Given that NSCLC can transform into multiple different SCLC subtypes [55,77], it will be interesting to determine if this role for SMAD4 is restricted to ASCL1-positive T-SCLC or if it is also relevant to other subtypes. Here, SMAD4 is linked to non-small cell lung carcinoma.